A. Ammassari

发表

Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance.

P. Narciso, A. Antinori, A. De Luca, 2003, Journal of Infectious Diseases.

Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy.

R. Maserati, G. d’Ettorre, A. Antinori, 2011, Journal of acquired immune deficiency syndromes.

Antiretroviral treatment‐based cost saving interventions may offset expenses for new patients and earlier treatment start

G. Ippolito, A. Mammone, P. Lorenzini, 2014, HIV medicine.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011.

M. Moroni, A. d’Arminio Monforte, A. Lazzarin, 2011, The new microbiologica.

A. Antinori, A. De Luca, A. Cingolani, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study

A. d’Arminio Monforte, G. Ippolito, A. Antinori, 2001, Journal of NeuroVirology.

Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers

A. Mocroft, A. d’Arminio Monforte, C. Sabin, 2017, PloS one.

Aerosolized pentamidine, cotrimoxazole and dapsone‐pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis

A. Antinori, A. Cingolani, G. Scoppettuolo, 1995, AIDS.

96 Week Follow-Up of HIV-Infected Patients in Rescue with Raltegravir Plus Optimized Backbone Regimens: A Multicentre Italian Experience

M. Meschiari, S. Lo Caputo, E. Ricci, 2012, PloS one.

Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, The Journal of antimicrobial chemotherapy.

Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.

A. Antinori, A. De Luca, C. Mussini, 2017, Annals of internal medicine.

Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort

A. d’Arminio Monforte, P. Cinque, F. Bai, 2017, PloS one.

Timing of Antiretroviral Therapy Initiation after a First AIDS-Defining Event: Temporal Changes in Clinical Attitudes in the ICONA Cohort

A. Antinori, A. De Luca, C. Mussini, 2014, PloS one.

Italian Consensus Statement on Management of HIV-Infected Individuals with Advanced Disease Naïve to Antiretroviral Therapy

A. d’Arminio Monforte, A. Lazzarin, M. Clerici, 2009, Infection.

AIDS-associated cerebral toxoplasmosis: an update on diagnosis and treatment.

A. Cingolani, R. Murri, A. Ammassari, 1996, Current topics in microbiology and immunology.

PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions.

A. De Luca, A. Cingolani, R. Murri, 1996, Journal of medical microbiology.

Evaluation of cerebrospinal fluid EBV‐DNA and IL‐10 as markers for in vivo diagnosis of AIDS‐related primary central nervous system lymphoma

L. Larocca, M. Scerrati, A. Antinori, 1995, British journal of haematology.

An anal cancer screening program for MSM in Italy: Prevalence of multiple HPV types and vaccine-targeted infections.

M. Capobianchi, P. Lorenzini, A. Ammassari, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.

C. Agrati, A. Antinori, A. Ammassari, 2018, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Epstein‐Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome–related primary central nervous system lymphoma

L. Larocca, G. Gaidano, A. Antinori, 1999, Annals of neurology.

Bone disease in HIV infection.

A. Ammassari, M. F. Saccomanno, M. Saccomanno, 2011, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma.

L. Larocca, M. Scerrati, A. Antinori, 1998, Journal of the National Cancer Institute.

Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2013, The Journal of antimicrobial chemotherapy.

Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy.

R. Porcher, C. Delaugerre, J. Molina, 2011, The Journal of antimicrobial chemotherapy.

Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures.

A. d’Arminio Monforte, V. Vullo, A. Antinori, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients.

A. Antinori, P. Cinque, V. Tozzi, 2006, AIDS research and human retroviruses.

A. Antinori, A. Monforte, M. Trotta, 2002, Journal of acquired immune deficiency syndromes.

Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults

A. Mocroft, C. Sabin, M. Battegay, 2015, AIDS.

Adherence to Antiretroviral Therapy: Where Are We, and Where Do We Go From Here?

A. Wu, A. Antinori, A. Ammassari, 2002, Journal of acquired immune deficiency syndromes.

Patient-reported nonadherence to HAART is related to protease inhibitor levels.

A. Wu, A. Antinori, D. Jacobson, 2000 .

Three-Year Clinical Outcomes of Resistance Genotyping and Expert Advice: Extended follow-up of the Argenta Trial

A. Cingolani, A. Ammassari, A. Luca, 2005, Antiviral therapy.

AVT-923 De Luca

A. Cingolani, A. Ammassari, A. Luca, 2006 .

Diagnosis of AIDS-related focal brain lesions

L. Larocca, M. Scerrati, A. Antinori, 1997, Neurology.

Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals.

V. Vullo, A. Antinori, V. Tozzi, 2008, AIDS patient care and STDs.

Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens.

P. Narciso, A. Antinori, A. De Luca, 2003, AIDS.

Comparison of Demand for Drugs Used for COVID-19 Treatment and Other Drugs During the Early Phase of the COVID-19 Pandemic in Italy

N. Magrini, M. Trotta, A. Ammassari, 2021, JAMA network open.

Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy

A. Antinori, A. De Luca, A. Cingolani, 2000, AIDS.

European Confederation of Medical Mycology (ECMM) prospective survey of cryptococcosis: report from Italy.

M. Moroni, S. Antinori, G. Michelone, 2002, Medical mycology.

Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes

L. Mele, L. Pagano, G. Leone, 1999, European journal of haematology.

Experience with brain biopsy in acquired immune deficiency syndrome‐related focal lesions of the central nervous system

M. Scerrati, R. Murri, A. Ammassari, 1994, The British journal of surgery.

Relative Prognostic Value of Self-Reported Adherence and Plasma Nnrti/Pi Concentrations to Predict Virological Rebound in Patients Initially Responding to Haart

D. Nauwelaers, P. Narciso, A. Antinori, 2004, Antiviral therapy.

A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry

C. Agrati, E. Cimini, A. Sacchi, 2018, PloS one.

Beyond Virological Suppression: The Role of Adherence in the Late Haart Era

A. Antinori, Noga Shalev, M. Trotta, 2012, Antiviral therapy.

HAART has increased the life expectancy of HIV-infected individuals significantly. Optimal adherence to HAART results in viral suppression and immune recovery in the majority of HIV-infected persons. Data from the early HAART

A. Antinori, Noga Shalev, M. Trotta, 2012 .

Fluconazole for primary prophylaxis of AIDS-associated cryptococcosis: a case-control study.

R. Murri, A. Ammassari, A. Antinori, 1995, Scandinavian journal of infectious diseases.

Reduced Rate of Diagnostic Positive Detection of JC Virus DNA in Cerebrospinal Fluid in Cases of Suspected Progressive Multifocal Leukoencephalopathy in the Era of Potent Antiretroviral Therapy

A. De Luca, A. Cingolani, S. Di Giambenedetto, 2005, Journal of Clinical Microbiology.

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy.

G. Ippolito, A. Antinori, V. Tozzi, 2001, AIDS.

Changing Clinical Presentation and Survival in HIV‐Associated Tuberculosis After Highly Active Antiretroviral Therapy

G. Ippolito, A. Antinori, A. De Luca, 2001, Journal of acquired immune deficiency syndromes.

Bone Marrow CD34+ Progenitor Cells from HIV-Infected Patients Show an Impaired T Cell Differentiation Potential Related to Proinflammatory Cytokines.

C. Agrati, E. Cimini, A. Sacchi, 2017, AIDS research and human retroviruses.

Impact of metabolic complications on antiretroviral treatment adherence: Clinical and public health implications

J. Nachega, M. Nelson, M. Trotta, 2009, Current HIV/AIDS reports.

Bone marrow CD34+ progenitor cells may harbour HIV-DNA even in successfully treated patients.

C. Agrati, V. Bordoni, F. Martini, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Incidence and Determinants of Bacterial Infections in HIV‐Positive Patients Receiving Anti‐Pneumocystis carinii/Toxoplasma gondii Primary Prophylaxis Within a Randomized Clinical Trial

A. Antinori, A. De Luca, A. Cingolani, 2001, Journal of acquired immune deficiency syndromes.

Simple and rapid two-step polymerase chain reaction for diagnosis of Pneumocystis carinii infection

A. Antinori, A. De Luca, E. Tamburrini, 1993, Journal of clinical microbiology.

Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens.

A. Antinori, A. De Luca, E. Tamburrini, 1993, Journal of medical microbiology.

Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas.

L. Larocca, E. Pescarmona, G. Gaidano, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature

A. Antinori, A. Ammassari, A. Vergori, 2017, BMC Infectious Diseases.

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Pietro Vernazza, Simon Collins, Gilles Wandeler, 2016, JAMA.

Self‐Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection

A. Wu, M. Moroni, P. Narciso, 2001, Journal of acquired immune deficiency syndromes.

Depression Is a Risk Factor for Suboptimal Adherence to Highly Active Antiretroviral Therapy

A. Wu, A. Antinori, A. Monforte, 2002, Journal of acquired immune deficiency syndromes.

L. Larocca, A. Antinori, A. Cingolani, 1999 .

Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study.

M. Meschiari, S. Lo Caputo, E. Ricci, 2014, International journal of antimicrobial agents.

Impact of Pre-Therapy Viral Load on Virological Response to Modern First-Line Haart

F. Ceccherini‐Silberstein, P. Narciso, E. Nicastri, 2013, Antiviral therapy.

Development and validation of an HPLC-UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV-positive patients.

L. Pucillo, A. Antinori, S. Fazio, 2018, Biomedical chromatography : BMC.

Definition and measurement of adherence to antiretroviral drugs in HIV-1-infected patients

A. Antinori, A. Cingolani, R. Murri, 1999, The Lancet.

Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort.

A. Antinori, R. Bellagamba, P. Lorenzini, 2015, Journal of acquired immune deficiency syndromes.

Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment

P. Narciso, E. Nicastri, A. Antinori, 2019, AIDS.

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

A. Antinori, R. Bellagamba, P. Lorenzini, 2014, Journal of the International AIDS Society.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons.

M. Moroni, A. d’Arminio Monforte, A. Lazzarin, 2011, The new microbiologica.

Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen

Domenico Di Carlo, F. Ceccherini‐Silberstein, R. Bellagamba, 2016, The Journal of antimicrobial chemotherapy.

Italian consensus statement on paediatric HIV infection

A. d’Arminio Monforte, C. Giaquinto, R. Badolato, 2010, Infection.

Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals

A. De Luca, A. Cingolani, B. Ciancio, 2002, Neurology.

Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy

L. Larocca, G. Ippolito, A. Antinori, 2001, AIDS.

L. Larocca, A. Cingolani, P. Pezzotti, 2000 .

L. Larocca, A. De Luca, A. Cingolani, 2000, Neurology.

Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection

W. Rozenbaum, N. Clumeck, F. Castelli, 1996, AIDS.

Patient‐Reported Nonadherence to HAART Is Related to Protease Inhibitor Levels

A. Wu, A. Antinori, D. Jacobson, 2000, Journal of acquired immune deficiency syndromes.

Oral human Papillomavirus DNA detection in HIV-positive men: prevalence, predictors, and co-occurrence at anal site

M. Capobianchi, A. Antinori, P. Piselli, 2018, BMC Infectious Diseases.

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

R. Talamini, A. Antinori, U. Tirelli, 2002, Blood.

Induced first abortion rates before and after HIV diagnosis: results of an Italian self‐administered questionnaire survey carried out in 585 women living with HIV

A. d’Arminio Monforte, G. d’Ettorre, P. Cicconi, 2013, HIV medicine.

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis

C. Marra, A. Antinori, P. Cinque, 2008, AIDS.

Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma.

L. Larocca, M. Scerrati, A. Antinori, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.

A. d’Arminio Monforte, A. Antinori, P. Cinque, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

disease and HIV infection Stanford V regimen and concomitant HAART in 59 patients with Hodgkin

R. Talamini, A. Antinori, U. Tirelli, 2013 .

Phase II controlled trial of post‐exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV‐1‐infected adults

A. Antinori, C. Tomino, R. Murri, 1998, AIDS (London).

Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection

C. Agrati, M. Capobianchi, A. Antinori, 2022, Pharmaceuticals.

IL‐18 and Stem Cell Factor affect hematopoietic progenitor cells in HIV‐infected patients treated during primary HIV infection

C. Agrati, E. Cimini, A. Sacchi, 2018, Cytokine.

Granulocytic Myeloid–Derived Suppressor Cells Increased in Early Phases of Primary HIV Infection Depending on TRAIL Plasma Level

C. Agrati, E. Cimini, A. Sacchi, 2017, Journal of acquired immune deficiency syndromes.

The Different Roles of Interleukin 7 and Interleukin 18 in Affecting Lymphoid Hematopoietic Progenitor Cells and CD4 Homeostasis in Naive Primary and Chronic HIV-Infected Patients.

C. Agrati, E. Cimini, A. Sacchi, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Early ART in primary HIV infection may also preserve lymphopoiesis capability in circulating haematopoietic progenitor cells: a case report.

C. Agrati, E. Cimini, A. Sacchi, 2015, The Journal of antimicrobial chemotherapy.

Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2018, The Journal of antimicrobial chemotherapy.

Slow or fast viral load decay as a predictor of residual viremia level in HIV-infected patients undergoing successful first-line cART.

M. Capobianchi, A. Antinori, E. Girardi, 2017, The new microbiologica.

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, BMC Public Health.

Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.

A. Wu, A. Antinori, A. Monforte, 2004, Psychosomatics.

Relationship Between HAART Adherence and Adipose Tissue Alterations

A. Wu, A. Antinori, A. Monforte, 2002, Journal of acquired immune deficiency syndromes.

Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration

J. Sterne, B. Yip, M. Gill, 2018, Journal of clinical medicine.

Patient-reported and physician-estimated adherence to HAART

Albert W. Wu, Rita Murri, A. Wu, 2004, Journal of General Internal Medicine.

Correlates and Predictors of Adherence to Highly Active Antiretroviral Therapy: Overview of Published Literature

A. Wu, P. Narciso, A. Antinori, 2002, Journal of acquired immune deficiency syndromes.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level Viremia

F. Ceccherini‐Silberstein, A. Antinori, C. Mussini, 2015, Journal of Clinical Microbiology.

Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels.

F. Ceccherini‐Silberstein, E. Nicastri, A. Antinori, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection

C. Agrati, E. Cimini, A. Sacchi, 2017, Journal of acquired immune deficiency syndromes.

Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy

A. Antinori, A. De Luca, A. Cingolani, 1996, Journal of clinical microbiology.

Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology.

A. d’Arminio Monforte, G. Ippolito, A. Lazzarin, 2014, The new microbiologica.

Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals

M. Capobianchi, A. Antinori, P. Lorenzini, 2017, PloS one.

Epstein-Barr V irus I nfection I s P redictive o f C NS Involvement i n S ystemic A IDS-Related N on-Hodgkin's Lymphomas

L. Larocca, E. Pescarmona, G. Gaidano, 2000 .

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

In HIV/HCV co-infected patients T regulatory and myeloid-derived suppressor cells persist after successful treatment with directly acting antivirals.

C. Agrati, E. Cimini, A. Sacchi, 2017, Journal of hepatology.

Changing disease patterns in focal brain lesion-causing disorders in AIDS.

A. Antinori, A. Cingolani, P. Pezzotti, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.

A. De Luca, A. Cingolani, G. Liuzzi, 2000, The Journal of infectious diseases.

Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era

G. Ippolito, A. Antinori, A. Cingolani, 2011, Journal of NeuroVirology.

Inconsistent condom use among HIV-positive women in the “Treatment as Prevention Era”: data from the Italian DIDI study

A. Monforte, D. Francisci, P. Cicconi, 2013, Journal of the International AIDS Society.

Sexual dysfunction in HIV infection

A. Antinori, A. Monforte, M. Trotta, 2007, The Lancet.

Adherence in HIV-positive patients treated with single-tablet regimens and multi-pill regimens: findings from the COMPACT study

A. Giannetti, C. Angeletti, E. Girardi, 2012, Journal of the International AIDS Society.

No significant association between patient self-reported non-adherence to antiretrovirals and HIV-tropism: a preliminary analysis

M. Capobianchi, P. Lorenzini, C. Perno, 2012, Journal of the International AIDS Society.

Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy.

G. Ippolito, A. Antinori, A. Cingolani, 2001 .

Physician Estimates of Adherence and the Patient‐Physician Relationship as a Setting to Improve Adherence to Antiretroviral Therapy

A. Wu, A. Antinori, N. Abrescia, 2002, Journal of acquired immune deficiency syndromes.

Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy

A. Antinori, A. Cingolani, A. Ammassari, 2005, Journal of NeuroVirology.

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)

A. Antinori, A. De Luca, A. Cingolani, 2002, AIDS.

Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy

A. d’Arminio Monforte, P. Lorenzini, C. Mussini, 2018, BMC Public Health.

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2018, BMC Medicine.

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.

F. Ceccherini‐Silberstein, E. Nicastri, C. Perno, 2015, The Journal of antimicrobial chemotherapy.

Correlates and predictors of adherence to HAART: overview of published literature.

P. Narciso, P. Noto, A. Monforte, 2002 .

Evidence of Dual Sexual Transmission of Multi-resistant HIV with Two Years Persistence of Resistance to NRTI and NNRTI: a Case Report

U. Visco-Comandini, C. Perno, C. Perno, 2008, Infection.

thology in the laryngeal abductor muscle. The mechanism of LS could contribute to heterogenous physiologic and pathologic le- sions of the central and peripheral nervous system in MSA

A. d’Arminio Monforte, R. Murri, A. Ammassari, 2003 .

Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group.

A. Antinori, A. De Luca, C. Mussini, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence of prolonged amenorrhea in HIV-infected women: results from the Italian DIDI study.

G. d’Ettorre, A. Monforte, P. Cicconi, 2012, Journal of acquired immune deficiency syndromes.

Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure.

Andrea De Luca, P. Narciso, A. Antinori, 2002, AIDS research and human retroviruses.

Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: Data from the Italian Registry Investigative Neuro AIDS (IRINA)

A. Antinori, P. Cinque, P. Lorenzini, 2011, Journal of NeuroVirology.

Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy.

A. De Luca, A. Cingolani, A. Ammassari, 1998, AIDS.

Karnofsky performance status and assessment of global health status.

G. Scoppettuolo, R. Murri, A. Ammassari, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Presumptive clinical criteria versus endoscopy in the diagnosis of Candida esophagitis at various HIV-1 disease stages.

A. De Luca, R. Masetti, E. Tamburrini, 1995, Endoscopy.

Association of Sofosbuvir and Daclatasvir Plasma Trough Concentrations with Patient-, Treatment-, and Disease-Related Factors Among HIV/HCV-Coinfected Persons

C. Agrati, A. Antinori, R. Bellagamba, 2021, European Journal of Drug Metabolism and Pharmacokinetics.

Association of Sofosbuvir and Daclatasvir Plasma Trough Concentrations with Patient-, Treatment-, and Disease-Related Factors Among HIV/HCV-Coinfected Persons

C. Agrati, A. Antinori, R. Bellagamba, 2021, European journal of drug metabolism and pharmacokinetics.

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication

A. Antinori, P. Lorenzini, E. Girardi, 2014, Journal of the International AIDS Society.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014.

A. d’Arminio Monforte, A. Lazzarin, A. Antinori, 2015, The new microbiologica.

Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals

E. Nicastri, A. Antinori, P. Balestra, 2014, Journal of the International AIDS Society.

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis

G. d’Ettorre, A. Giannetti, A. Antinori, 2014, Journal of the International AIDS Society.

Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity

A. d’Arminio Monforte, R. Murri, A. Ammassari, 2003, Neurology.

Role of brain biopsy in the management of focal brain lesions in HIV-infected patients

M. Scerrati, G. Butti, R. Maserati, 2000, Neurology.

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study

G. d’Ettorre, A. Giannetti, A. Antinori, 2016, BMC Infectious Diseases.

Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000–14

A. Mariano, F. Ceccherini‐Silberstein, V. Vullo, 2017, The Journal of antimicrobial chemotherapy.

Chronic HIV-Infected Patients Show an Impaired Dendritic Cells Differentiation of Bone Marrow CD34+ Cells

C. Agrati, A. Sacchi, V. Bordoni, 2013, Journal of acquired immune deficiency syndromes.

HIV-1 infection and progressive multifocal leukoencephalopathy in a person without detectable HIV antibodies.

A. De Luca, A. Cingolani, C. Perno, 1998, AIDS.

Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/hepatitis C virus co-infected patients

A. De Luca, A. Cingolani, E. Tamburrini, 2004, AIDS.

'Buffalo hump' in HIV-1 infection (multiple letters) [4]

A. Antinori, K. Fattinger, R. Murri, 1998 .

Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study.

A Ammassari, A. De Luca, A. Cingolani, 2000, AIDS.

Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy.

A. Antinori, A. De Luca, A. Cingolani, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Oral lesions in HIV and HCV co-infected individuals in HAART era.

E. Tamburrini, A. Ammassari, M. Giuliani, 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects

A. Antinori, P. Lorenzini, A. Ammassari, 2019, Infection.

A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.

M. Moroni, L. Contu, A. Lazzarin, 2000, AIDS Research and Human Retroviruses.

Acute HIV infection (AHI) in a specialized clinical setting: case-finding, description of virological, epidemiological and clinical characteristics

F. Martini, A. Antinori, V. Puro, 2014, Journal of the International AIDS Society.

Immune Status and Serial Quantiferon-TB Gold In-Tube Screening for Latent Mycobacterium tuberculosis Infection Among HIV-Infected Persons in a Country With a Low Tuberculosis Incidence.

A. Mammone, R. Bellagamba, D. Goletti, 2015, The Journal of infectious diseases.

Liver stiffness reduction and serum fibrosis score improvement in HIV/hepatitis C virus‐coinfected patients treated with direct‐acting antivirals

A. Antinori, R. Bellagamba, P. Lorenzini, 2018, HIV medicine.

Nosocomial Infection Rates in an Italian Intensive Care Unit Using the National Nosocomial Infection Surveillance System

M. Pennisi, F. Leone, R. Proietti, 2001, Infection Control & Hospital Epidemiology.

Discrepancies between physician's perception of depression in HIV patients and self-reported CES-D-20 assessment: the DHIVA study

A. Ammassari, G. Gualberti, M. Galli, 2015, AIDS care.

Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial

A. Antinori, F. Raffi, W. Stöhr, 2018, Journal of acquired immune deficiency syndromes.

Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial

A. Antinori, F. Raffi, W. Stöhr, 2018, Journal of acquired immune deficiency syndromes.

Phenotypic profile and change in cerebrospinal fluid EBV-DNA burden during therapy as prognostic factors in AIDS-related primary central nervous system lymphoma

L. Larocca, G. Gaidano, A. Antinori, 1998 .

Primary central nervous system lymphoma and brain biopsy in AIDS

M. Scerrati, A. Antinori, G. A. Cèfaro, 1993, The Lancet.

Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.

A. De Luca, A. Cingolani, R. Murri, 2000, AIDS research and human retroviruses.

Erratum: Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma (British Journal of Haematology, 90, 844-849, (1995))

L. Larocca, M. Scerrati, A. Antinori, 1995 .

Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world

C. Agrati, A. Antinori, R. Bellagamba, 2018, The Journal of antimicrobial chemotherapy.

Failure of cytarabine and increased JC virus-DNA burden in the cerebrospinal fluid of patients with AIDS-related progressive multifocal leucoencephalopathy.

M. Scerrati, A. De Luca, A. Cingolani, 1994, AIDS.

Prevalence and Associated Factors of Neurocognitive Impairment in HIV-Positive Patients on Effective Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Treatment.

P. Narciso, E. Nicastri, A. Antinori, 2018, AIDS research and human retroviruses.

Detection of T.gundii‐DNA by PCR in AIDS‐related toxoplasmic encephalitis.

A. Antinori, A. Cingolani, R. Murri, 1996, The Journal of eukaryotic microbiology.

First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, A. Lazzarin, 2018, HIV medicine.

Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS‐related Kaposi's sarcoma

A. Antinori, U. Tirelli, E. Vaccher, 1996, Cancer.

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.

Domenico Di Carlo, F. Ceccherini‐Silberstein, M. Andreoni, 2015, The Journal of antimicrobial chemotherapy.

K. Jellinger, L. Larocca, A. Cingolani, 2000, Neurology.

Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.

A. Antinori, G. Scambia, E. Tamburrini, 2015, AIDS.

Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study

A. d’Arminio Monforte, G. Ippolito, A. Antinori, 2001, Journal of NeuroVirology.

Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.

A. d’Arminio Monforte, A. Antinori, P. Cinque, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: a multicentre study.

A. Antinori, V. Tozzi, A. Cingolani, 2000, AIDS.

Self-Reported Nonadherence with Antiretroviral Drugs Predicts Persistent Condition

A. Antinori, A. De Luca, A. Cingolani, 2001, HIV clinical trials.

Adherence to Protease Inhibitors

A Ammassari, A Antinori, A. Antinori, 2001, Annals of Internal Medicine.

Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients

A. Antinori, C. Mussini, J. Fehr, 2016 .